• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number MICL12.6
Medical Device Problem Codes Misfocusing (1401); Inadequacy of Device Shape and/or Size (1583); Patient-Device Incompatibility (2682); Optical Problem (3001)
Health Effect - Clinical Codes Intraocular Pressure Increased (1937); Blurred Vision (2137); Visual Disturbances (2140); Halo (2227); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 02/09/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This product is not marketed in the us.(b)(4).
 
Event or Problem Description
The reporter indicated that a 12.6mm, micl12.6, -9.0 diopter, implantable collamer lens was implanted into the patient's left eye (os) on (b)(6) 2021.Significant reduction of irido-corneal angels, blurred vision, glare/haloes, and excessive vault were observed, the lens was exchanged for a shorter length lens on (b)(6) 2021 and the problem was resolved.Cause of the event is reported as patient-related factor, "unusual anatomy".Reportedly, "all looks good, much less glare in new lens per patient.".
 
Additional Manufacturer Narrative
H3 - device evaluation: lens was returned in vial, in liquid.Visual inspection found haptic torn.Claim# (b)(4).
 
Additional Manufacturer Narrative
The reporter indicated that a 12.6mm, micl12.6, -9.0 diopter, implantable collamer lens was implanted into the patient's left eye (os) on (b)(6) 2021.Significant reduction of irido-corneal angles, elevated iop, blurred vision, glare/haloes, and excessive vault were observed, the lens was exchanged for a shorter length lens on (b)(6) 2021 and the problem was resolved.Cause of the event is reported as patient-related factor, "unusual anatomy".Reportedly, "all looks good, much less glare in new lens per patient." d9- changed to (b)(6) 2021.Claim#: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Common Device Name
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
MDR Report Key11416096
Report Number2023826-2021-00507
Device Sequence Number3544765
Product Code MTA
UDI-Device Identifier00841542103008
UDI-Public00841542103008
Combination Product (Y/N)Y
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
P030016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2022
Device Model NumberMICL12.6
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2021
Initial Date Received by Manufacturer 02/09/2021
Supplement Date Received by Manufacturer04/13/2021
10/12/2021
Initial Report FDA Received Date03/04/2021
Supplement Report FDA Received Date05/05/2021
10/12/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
UNK.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age28 YR
-
-